665
Views
15
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH REPORT

Carbon dioxide laser combined with botulinum toxin A for patients with periorbital syringomas

, , &
Pages 149-153 | Received 05 Mar 2015, Accepted 21 Apr 2015, Published online: 31 Mar 2016

References

  • Patrizi A, Neri I, Marzaduri S, Varotti E, Passarini B. Syringoma: a review of twenty-nine cases. Acta Derm Venereol. 1998;78:460–462.
  • Park HJ, Lee DY, Lee JH, Yang JM, Lee ES, Kim WS. The treatment of syringomas by CO(2) laser using a multiple-drilling method. Dermatol Surg. 2007;33:310–313.
  • Iwao F, Onozuka T, Kawashima T. Vulval syringoma successfully treated with tranilast. Br J Dermatol. 2005;153:1228–1230.
  • Ambache N. A further survey of the action of Clostridium botulinum toxin upon different types of autonomic nerve fibre. J Physiol. 1951;113:1–17.
  • Naumann M, Hofmann U, Bergmann I, Hamm H, Toyka KV, Reiners K. Focal hyperhidrosis: effective treatment with intracutaneous botulinum toxin. Arch Dermatol. 1998;134:301–304.
  • Gandhi V, Naik G, Verma P. Eccrine hidrocystoma successfully treated with topical synthetic botulinum Peptide. J Cutan Aesthet Surg. 2011;4:154–155.
  • Blugerman G, Schavelzon D, D’Angelo S. Multiple eccrine hidrocystomas: a new therapeutic option with botulinum toxin. Dermatol Surg. 2003;29:557–559.
  • Correia O, Duarte AF, Barros AM, Rocha N. Multiple eccrine hidrocystomas–from diagnosis to treatment: the role of dermatoscopy and botulinum toxin. Dermatology. 2009; 219:77–79.
  • Ebrahimi A, Radmanesh M. Botulinum toxin type-A (BT-A) for the treatment of multiple eccrine hydrocystomas. J Dermatolog Treat. 2010;21:80–82.
  • Kontochristopoulos G, Markantoni V, Stefanaki C, Kanelleas A, Rigopoulos D, Gregoriou S. Multiple eccrine hidrocystomas treated with botulinum toxin A. Clin Exp Dermatol. 2011;36:95–96.
  • Woolery-Lloyd H, Rajpara V, Nijhawan RI. Treatment for multiple periorbital eccrine hidrocystomas: botulinum toxin A. J Drugs Dermatol. 2009;8:71–73.
  • Aoki KR. Pharmacology and immunology of botulinum toxin serotypes. J Neurol. 2001;248:3–10.
  • Baron ED, Harris L, Redpath WS, Shapiro H, Hetzel F, Morley G, et al. Laser-assisted penetration of topical anesthetic in adults. Arch Dermatol. 2003;139:1288–1290.
  • Lee WR, Shen SC, Kuo-Hsien W, Hu CH, Fang JYShapiro HHetzel FMorley G. Lasers and microdermabrasion enhance and control topical delivery of vitamin C. J Invest Dermatol. 2003;121:1118–1125.
  • Paasch U, Haedersdal M. Laser systems for ablative fractional resurfacing. Expert Rev Med Devices. 2011;8:67–83.
  • Waibel J, Beer K, Narurkar V, Alster T. Preliminary observations on fractional ablative resurfacing devices: clinical impressions. J Drugs Dermatol. 2009;8:481–485.
  • Sklar LR, Burnett CT, Waibel JS, Moy RL, Ozog DM. Laser assisted drug delivery: a review of an evolving technology. Lasers Surg Med. 2014;46:249–262.
  • Drobik C, Laskawi R. Frey's syndrome: treatment with botulinum toxin. Acta Otolaryngol. 1995;115:459–461.
  • Sanchez TS, Dauden E, Casas AP, García-Díez A. Eruptive pruritic syringomas: treatment with topical atropine. J Am Acad Dermatol. 2001;44:148–149.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.